HK1252412A1 - 多肽用於作用於免疫信号转导和/或影响肠屏障功能和/或调节代谢状态的用途 - Google Patents

多肽用於作用於免疫信号转导和/或影响肠屏障功能和/或调节代谢状态的用途 Download PDF

Info

Publication number
HK1252412A1
HK1252412A1 HK18111709.9A HK18111709A HK1252412A1 HK 1252412 A1 HK1252412 A1 HK 1252412A1 HK 18111709 A HK18111709 A HK 18111709A HK 1252412 A1 HK1252412 A1 HK 1252412A1
Authority
HK
Hong Kong
Prior art keywords
polypeptide
metabolic status
barrier function
intestinal barrier
gut mucosal
Prior art date
Application number
HK18111709.9A
Other languages
English (en)
Chinese (zh)
Inventor
Clara BELZER
Willem Meindert De Vos
Patrice Daniel Cani
Original Assignee
Wageningen Universiteit
Université Catholique de Louvain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wageningen Universiteit, Université Catholique de Louvain filed Critical Wageningen Universiteit
Publication of HK1252412A1 publication Critical patent/HK1252412A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK18111709.9A 2015-05-06 2016-05-04 多肽用於作用於免疫信号转导和/或影响肠屏障功能和/或调节代谢状态的用途 HK1252412A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15166598.1 2015-05-06
EP15166598 2015-05-06
PCT/EP2016/060033 WO2016177797A1 (en) 2015-05-06 2016-05-04 Use of a polypeptide for effecting immune signalling and/or affecting intestinal barrier function and/or modulating metabolic status

Publications (1)

Publication Number Publication Date
HK1252412A1 true HK1252412A1 (zh) 2019-05-24

Family

ID=74184294

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18111709.9A HK1252412A1 (zh) 2015-05-06 2016-05-04 多肽用於作用於免疫信号转导和/或影响肠屏障功能和/或调节代谢状态的用途

Country Status (14)

Country Link
US (2) US10738089B2 (https=)
EP (1) EP3292135B1 (https=)
JP (1) JP6894382B2 (https=)
KR (1) KR102736980B1 (https=)
CN (1) CN107980043B (https=)
AU (2) AU2016257315A1 (https=)
DK (1) DK3292135T3 (https=)
EA (1) EA201700507A1 (https=)
ES (1) ES2934138T3 (https=)
HK (1) HK1252412A1 (https=)
IL (1) IL255405B (https=)
MX (1) MX390092B (https=)
PL (1) PL3292135T3 (https=)
WO (1) WO2016177797A1 (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201903823QA (en) 2014-10-31 2019-05-30 Whole Biome Inc Methods and compositions relating to microbial treatment and diagnosis of disorders
PL3292135T3 (pl) 2015-05-06 2023-01-02 Wageningen Universiteit Zastosowanie polipeptydu do wpływania na sygnalizację odpornościową i/lub wpływania na funkcję bariery jelitowej i/lub modulowania stanu metabolicznego
PT3626081T (pt) * 2015-09-10 2022-02-25 Univ Catholique Louvain Akkermansia pasteurizada para promover a perda de peso
US11931400B2 (en) 2017-03-07 2024-03-19 Psomagen, Inc. Therapeutic and diagnostics compositions targeting toll-like receptors and methods thereof
WO2019018410A1 (en) * 2017-07-17 2019-01-24 The General Hospital Corporation COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASES
CN111372596A (zh) 2017-08-30 2020-07-03 潘德勒姆治疗公司 用于治疗微生物组相关病症的方法和组合物
CA3106315A1 (en) 2018-07-19 2020-01-23 Pendulum Therapeutics, Inc. Methods and compositions for microbial engraftment
WO2020076043A1 (ko) * 2018-10-08 2020-04-16 한국생명공학연구원 우울증의 예방 또는 치료 효과를 가지는 장내 미생물 및 이의 용도
KR102197180B1 (ko) * 2018-10-11 2020-12-31 주식회사 고바이오랩 아커만시아 뮤시니필라 균주 및 이를 포함하는 식욕 억제 및 대사성 질환 예방, 개선, 완화 및 치료용 조성물
CN110079474B (zh) * 2019-04-12 2022-11-25 沈阳药科大学 一种高密度培养艾克曼嗜黏蛋白菌的方法
WO2020226438A1 (ko) * 2019-05-07 2020-11-12 한국생명공학연구원 염증성 장질환의 예방 또는 치료용 펩타이드
CN110227085A (zh) * 2019-07-16 2019-09-13 江苏省中医院 Akkermansia Muciniphila在制备抗抑郁药物或者保健品中的应用
EP4079837A4 (en) * 2019-09-25 2024-06-05 HealthBiome, Inc. OBLIGATE ANAEROBIC HUMAN INTESTINAL MICROBES FOR CANCER TREATMENT AND ITS USE
KR102397916B1 (ko) * 2019-10-01 2022-05-17 (주)헬스바이옴 건강한 임산부 모유 유래 혐기성 인체 균주 및 이를 이용한 대사성 질환의 예방 또는 치료방법
CN110950937B (zh) * 2019-11-25 2021-05-04 安徽大学 一种改造的艾克曼菌Amuc_1100蛋白及其制备方法和应用
US11666629B2 (en) * 2020-01-10 2023-06-06 National Taipei University Of Technology Peptide interacting with toll-like receptor 2 and the composition comprising the same
CN115666627A (zh) * 2020-03-25 2023-01-31 韩国生命工学研究院 源自嗜黏蛋白阿克曼菌的tars或其片段,及其用途
US20210322492A1 (en) * 2020-04-16 2021-10-21 Amucin Oy Ltd Probiotic strains and uses thereof
CN111690044B (zh) * 2020-05-06 2022-03-01 中南大学湘雅二医院 Amuc1100蛋白的用途
CN115996943A (zh) * 2020-07-01 2023-04-21 瓦赫宁根大学 用于影响免疫信号传导和/或影响肠屏障功能和/或调节代谢状态的Amuc-1100多肽变体
WO2022098051A1 (ko) * 2020-11-05 2022-05-12 한국생명공학연구원 항염 및 조직 재생작용을 갖는 신규 펩타이드
CN113413466B (zh) * 2020-12-15 2022-08-19 和度生物医药(上海)有限公司 用于治疗癌症的amuc_1100和免疫检查点调节剂的组合疗法
CN115364198A (zh) * 2022-08-23 2022-11-22 广州康泽医疗科技有限公司 膜蛋白Amuc_1100在促进前脂肪细胞脂解和棕色化中的应用
CN116059254B (zh) * 2023-02-27 2025-04-18 广州知易生物科技有限公司 嗜黏蛋白阿克曼氏菌在制备用于改善和治疗多发性硬化症药物中的应用
KR102835266B1 (ko) 2023-09-11 2025-07-17 충남대학교산학협력단 아커만시아 뮤시니필라 m3-2 균주 및 이의 용도
CN117304264B (zh) * 2023-11-27 2024-02-06 中国科学院烟台海岸带研究所 一种具有肠屏障保护功能的五肽rp5及其应用
CN118063567B (zh) * 2024-03-03 2025-11-21 吉林大学 一种用于炎性肠病治疗的重组蛋白的制备与应用
CN119874827B (zh) * 2025-03-27 2025-06-13 杭州康源食品科技有限公司 一种具有免疫调节作用的九肽及其制备和应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102872A (en) * 1985-09-20 1992-04-07 Cetus Corporation Controlled-release formulations of interleukin-2
NL1014380C2 (nl) 2000-02-14 2001-08-15 Friesland Brands Bv Darmwandversterkend voedingsmiddel.
JP3932358B2 (ja) * 2001-02-28 2007-06-20 独立行政法人産業技術総合研究所 ブラディオン遺伝子導入ショウジョウバエ株
CA2511775A1 (en) * 2002-12-10 2004-06-24 Epimmune Inc. Hla-a1,-a2 -a3,-a24,-b7,and -b44 tumor associated antigen peptides and compositions
WO2004069156A2 (en) 2003-01-30 2004-08-19 The Regents Of The University Of California Inactivated probiotic bacteria and methods of use thereof
WO2005030133A2 (en) 2003-09-22 2005-04-07 Yale University Treatment with agonists of toll-like receptors
US20060281818A1 (en) 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
WO2008028117A2 (en) 2006-08-31 2008-03-06 Centocor, Inc. Glp-2 mimetibodies, polypeptides, compositions, methods and uses
EP2102350A4 (en) 2006-12-18 2012-08-08 Univ St Louis DARMMICROBIOMA AS A BIOMARKER AND THERAPEUTIC OBJECT FOR THE TREATMENT OF ADIPOSITAS OR ADIPOSITASCONDUCTIVE DISEASES
EP2030623A1 (en) 2007-08-17 2009-03-04 Nestec S.A. Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria
FR2944524B1 (fr) 2009-04-17 2012-11-30 Ipsen Pharma Sas Derives d'imidazolidine-2,4-dione et leur utilisation comme medicament
US8784798B2 (en) 2009-05-11 2014-07-22 Nestec S.A. Bifidobacterium longum NCC2705 (CNCM I-2618) and immune disorders
WO2011137369A1 (en) * 2010-04-29 2011-11-03 The Regents Of The University Of California Production of gamma-aminobutyric acid by recombinant microorganisms
US9104670B2 (en) 2010-07-21 2015-08-11 Apple Inc. Customized search or acquisition of digital media assets
US10393778B2 (en) 2010-10-20 2019-08-27 Signify Holding B.V. Disaggregation apparatus
EP2449891A1 (en) 2010-11-05 2012-05-09 Nestec S.A. Drinking yoghurt preparations containing non-replicating probiotic micro-organisms
EP2449887B1 (en) 2010-11-05 2016-01-06 Nestec S.A. Method for preparing pet food containing probiotic micro-organisms
IN2014DN07752A (https=) 2012-02-29 2015-05-15 Ethicon Endo Surgery Inc
WO2014075745A1 (en) 2012-11-19 2014-05-22 Université Catholique de Louvain Use of akkermansia for treating metabolic disorders
KR101740893B1 (ko) * 2014-05-20 2017-06-13 주식회사 엠디헬스케어 Akkermansia muciniphila 균에서 유래하는 세포밖 소포를 유효성분으로 함유하는 대사질환의 치료 또는 예방용 조성물
PL3292135T3 (pl) 2015-05-06 2023-01-02 Wageningen Universiteit Zastosowanie polipeptydu do wpływania na sygnalizację odpornościową i/lub wpływania na funkcję bariery jelitowej i/lub modulowania stanu metabolicznego
PT3626081T (pt) 2015-09-10 2022-02-25 Univ Catholique Louvain Akkermansia pasteurizada para promover a perda de peso
US11071626B2 (en) 2018-03-16 2021-07-27 W. L. Gore & Associates, Inc. Diametric expansion features for prosthetic valves

Also Published As

Publication number Publication date
US11466057B2 (en) 2022-10-11
WO2016177797A1 (en) 2016-11-10
EP3292135B1 (en) 2022-09-21
IL255405B (en) 2022-01-01
MX390092B (es) 2025-03-11
NZ737765A (en) 2024-08-30
IL255405A0 (en) 2017-12-31
KR20180011130A (ko) 2018-01-31
PL3292135T3 (pl) 2023-01-02
EP3292135A1 (en) 2018-03-14
AU2016257315A1 (en) 2017-11-23
JP6894382B2 (ja) 2021-06-30
AU2020267210A1 (en) 2020-12-17
AU2020267210B2 (en) 2023-10-12
US20210147489A1 (en) 2021-05-20
JP2018515502A (ja) 2018-06-14
KR102736980B1 (ko) 2024-12-02
CN107980043A (zh) 2018-05-01
CA2984985A1 (en) 2016-11-10
US10738089B2 (en) 2020-08-11
MX2017014111A (es) 2018-02-26
BR112017023751A2 (pt) 2018-07-31
DK3292135T3 (da) 2022-10-31
EA201700507A1 (ru) 2018-05-31
US20180265554A1 (en) 2018-09-20
ES2934138T3 (es) 2023-02-17
CN107980043B (zh) 2021-09-24

Similar Documents

Publication Publication Date Title
HK1252412A1 (zh) 多肽用於作用於免疫信号转导和/或影响肠屏障功能和/或调节代谢状态的用途
ZA201805385B (en) Computer security based on artificial intelligence
EP3262559A4 (en) System and method to mitigate malware
EP3123399A4 (en) System for filtering, segmenting and recognizing objects in unconstrained environments
HUE048956T2 (hu) Kijelzõbe integrált felhasználóosztályozó-, biztonsági- és ujjlenyomat-olvasó rendszer
EP3218845A4 (en) Facial liveness detection in image biometrics
EP3166675A4 (en) Facial access oxygen face mask and component system
IL257040B (en) Systems and processes for executing private programs on untrusted computers
EA201791426A1 (ru) Полипептид и иммуномодуляция
EP3131566A4 (en) Bi-terminal pegylated integrin-binding peptides and methods of use thereof
GB2559275B (en) Methods and systems for performing actions based on biometric data
EP3167359A4 (en) USING INDIVIDUALIZED APIs TO BLOCK AUTOMATED ATTACKS ON NATIVE APPS AND/OR PURPOSELY EXPOSED APIs
EP3218842A4 (en) Facial spoofing detection in image based biometrics
EP3239893A4 (en) Fingerprint detection circuit and fingerprint recognition system
EP3304329A4 (en) Break state detection in content management systems
GB201610489D0 (en) Methods and compositions for modulating the immune system with Arginase I
EP3126023A4 (en) Vision system for monitoring board games and method thereof
EP3315607A4 (en) Cell-free dna capture platform using conductive polymer and use of the platform
EP3115830A4 (en) Decentered type contact lens and decentered type contact lens set
EP3133927A4 (en) Shrimp processing system and methods
DK3808188T1 (da) Fiskefoder og fremgangsmåde til smoltifikation og forebyggelse af desmoltifikation hos salmonidae samt til profylakse og behandling af hæmoragisk smoltsyndrom (hss) hos salmonidae
EP3157215A4 (en) Interface circuit and information processing system
EP3155218A4 (en) Kick detection systems and methods
EP3239894A4 (en) Fingerprint detection circuit and fingerprint recognition system
IL247551B (en) A peptide drug in the form of a dry powder